Centre of Excellence mid-term evaluation:

Centre for Cancer Biomedicine and Centre for Immune Regulation ranked "exceptionally good"

The Research Council of Norway has recently completed a mid-term evaluation of 8 Centres of Excellence that were inaugurated in 2007. Two centres located at Oslo University Hospital, Centre for Cancer Biomedicine (CCB) and Centre for Immune Regulation (CIR) were both ranked with the highest obtainable score, "exceptionally good".

The international evaluation panel, led by professor Sten Grillner (Nobel Institute for Neurophysiology, Karolinska Institute; previous chairman of the Nobel Committee for Physiology or Medicine), concluded that "CCB is delivering, at a very high level, what is expected from a national CoE - clear international scientific impact combined with a societal impact in the form of better cancer patient care." Likewise, the panel concluded that "CIR has delivered frontier research and applications at a very high level. The fundamental and application-oriented groups have found a very fruitful way of working together, augmenting in a reciprocal way each other’s research agendas."

Links:

Complete evaluation report from The Norwegian Research Council (pdf format)

Centre for Cancer Biomedicine (CCB)

Centre for Immune Regulation (CIR)